The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
Open accessAbstract
Inhaled corticosteroids (ICS) are important in reducing exacerbation frequency associated with chronic obstructive pulmonary disease (COPD). However, little is known about the risk of associated infections. In a post hoc analysis of the TOwards a Revolution in COPD Health (TORCH) study, we analysed and identified potential risk factors for adverse event reports of pneumonia in this randomised, double-blind trial comparing twice-daily inhaled salmeterol (SAL) 50 μg, fluticasone propionate (FP) 500 μg, and the combination (SFC) with placebo in 6,184 patients with moderate-to-severe COPD over 3 yrs. Despite a higher withdrawal rate in the placebo arm, after adjusting for time on treatment, a greater rate of pneumonia was reported in the FP and SFC treatment arms (84 and 88 per 1,000 treatment-yrs, respectively) compared with SAL and placebo (52 and 52 per 1,000 treatment-yrs, respectively). Risk factors for pneumonia were age ≥55 yrs, forced expiratory volume in 1 s <50% predicted, COPD exacerbations in the year prior to the study, worse Medical Research Council dyspnoea scores and body mass index <25 kg·m −2 . No increase in pneumonia deaths with SFC was observed; this could not be concluded for FP. Despite the benefits of ICS-containing regimens in COPD management, healthcare providers should remain vigilant regarding the possible development of pneumonia as a complication in COPD patients receiving such therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Self-citationCalverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A., Anderson, J., & Maden, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12459-2 · Cited by 1,221
Self-citationInfections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072 · cited 1×
“In addition, cross-sectional studies have shown increased microbiological colonisation of the lower respiratory tract during exacerbations of COPD compared with the stable state [15, 16].”
BackgroundWedzicha, J. A., Calverley, P. M. A., Seemungal, T. A., Hagan, G., Ansari, Z., & Stockley, R. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-973oc · Cited by 827
Self-citationMaintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
Calverley, P. M., Boonsawat, W., Cseke, Z., Zhong, N., Peterson, S., & Olsson, H. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00027003 · Cited by 730
Self-citationBacterial Infection in Chronic Obstructive Pulmonary Disease
Murphy, T. F., & Sethi, S. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.4.1067 · Cited by 580
Monsó, E., Ruiz, J., Rosell, A., Manterola, J., Fiz, J., Morera, J., & Ausina, V (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551388 · Cited by 562
McGarvey, L. P., John, M., Anderson, J. A., Zvarich, M., & Wise, R. A. (2007) · Thorax · doi:10.1136/thx.2006.072348 · Cited by 561
Self-citationHodge, S., Hodge, G., Scicchitano, R., Reynolds, P. N., & Holmes, M. (2003) · Immunology & Cell Biology · doi:10.1046/j.1440-1711.2003.t01-1-01170.x · Cited by 440
Fry, A. M. (2005) · JAMA · doi:10.1001/jama.294.21.2712 · Cited by 425
Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001
Holguin, F., Folch, E., Redd, S. C., & Mannino, D. M. (2005) · Chest · doi:10.1378/chest.128.4.2005 · Cited by 396
Ernst, P., Gonzalez, A. V., Brassard, P., & Suissa, S. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200611-1630oc · Cited by 389
Airway Inflammation and Bronchial Bacterial Colonization in Chronic Obstructive Pulmonary Disease
Sethi, S., Maloney, J., Grove, L., Wrona, C., & Berenson, C. S. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1525oc · Cited by 373
Airway Bacterial Load and FEV 1 Decline in Patients with Chronic Obstructive Pulmonary Disease
Wilkinson, T. M. A., Patel, I. S., Wilks, M., Donaldson, G. C., & Wedzicha, J. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1179oc · Cited by 370
Cabello, H., Torres, A., Celis, R., El-Ebiary, M., Puig de la Bellacasa, J., Xaubet, A., Gonzalez, J., Agusti, C., & Soler, N. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10051137 · Cited by 284
COPD is associated with increased mortality in patients with community-acquired pneumonia
Restrepo, M. I., Mortensen, E. M., Pugh, J. A., & Anzueto, A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00131905 · Cited by 268
Antiinflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Lung Disease
Barnes, N. C., Qiu, Y.-S., Pavord, I. D., Parker, D., Davis, P. A., Zhu, J., Johnson, M., Thomson, N. C., & Jeffery, P. K. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1321oc · Cited by 253
Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
Ferguson, G. T., Anzueto, A., Fei, R., Emmett, A., Knobil, K., & Kalberg, C. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.04.019 · Cited by 232
Self-citationThe TORCH (TOwards a Revolution in COPD Health) survival study protocol: Fig. 1.—
The TORCH Study Group (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00120603 · Cited by 224
Decreased Contents of Surfactant Proteins A and D in BAL Fluids of Healthy Smokers
Honda, Y., Takahashi, H., Kuroki, Y., et al. (1996) · CHEST Journal · doi:10.1378/chest.109.4.1006 · Cited by 207
Risk factors for community-acquired pneumonia diagnosed upon hospital admission
Farr, B. M., Bartlett, C. L. R., Wadsworth, J., & Miller, D. L. (2000) · Respiratory Medicine · doi:10.1053/rmed.2000.0865 · Cited by 166
Pneumonic vs Nonpneumonic Acute Exacerbations of COPD
Lieberman, D. B., Lieberman, D., Gelfer, Y., Varshavsky, R., Dvoskin, B., Leinonen, M., & Friedman, M. G. (2002) · CHEST Journal · doi:10.1378/chest.122.4.1264 · Cited by 136
I, A. P., Reyes, E., Bernstein, E. D., MARTINEZ, B., Monserrat, J., IZQUIERDO, J. L., Callol, L., de Lucas, P., Álvarez-Sala, R., Álvarez-Sala, J. L., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2002015 · Cited by 120
Lange, P., Vestbo, J., & Nyboe, J. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08101694 · Cited by 105
Self-citationBloemen, P. G. M., van den Tweel, M. C., Henricks, P. A. J., Engels, F., Kester, M. H. A., de Loo, P. G. F. V., Blomjous, F. J. E. M., & Nijkamp, F. P. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.272.4.l580 · Cited by 102
Impaired Neutrophil Chemotaxis in Chronic Obstructive Pulmonary Disease
Yoshikawa, T., Dent, G., Ward, J., Angco, G., Nong, G., Nomura, N., Hirata, K., & Djukanović, R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200507-1152oc · Cited by 68
Mobbs, K. J., van Saene, H. K. F., Sunderland, D., & Davies, P. D. O. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90152-x · Cited by 66
Effects of alcohol and nicotine on cytotoxic functions of human lymphocytes
Nair, M., Kronfol, Z., & Schwartz, S. A. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90053-s · Cited by 64
Yıldız, F., Kaur, A., Ilgazlı, A., Celikoglu, M., Özkara, S. K., Paksoy, N., & Özkarakaş, O. (2000) · Respiration · doi:10.1159/000029466 · Cited by 63
Haemophilus influenzae Induces Neutrophil Necrosis
Naylor, E. J., Bakstad, D., Biffen, M., Thong, B., Calverley, P. M., Scott, S., Hart, C. A., Moots, R. J., & Edwards, S. W. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0375oc · Cited by 47
Self-citationInhibitory effect of salmeterol on the respiratory burst of adherent human neutrophils
Ottonello, L. C., Morone, P., Dapino, P., & Dallegri, F. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-804.x · Cited by 37
Jeffery, P. K. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.5.619 · Cited by 12
Cited by
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
Chronic obstructive pulmonary disease
Rabe, K. F., & Watz, H. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31222-9 · Cited by 960
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Wedzicha, J. A., Banerji, D., Chapman, K. R., Vestbo, J., Roche, N., Ayers, R. T., Thach, C., Fogel, R., Patalano, F., & Vogelmeier, C. F. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516385 · Cited by 844
Self-citationPascoe, S., Locantore, N., Dransfield, M. T., Barnes, N. C., & Pavord, I. D. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00106-x · Cited by 743
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
Pavord, I. D., Chanez, P., Criner, G. J., Kerstjens, H. A. M., Korn, S., Lugogo, N., Martinot, J.-B., Sagara, H., Albers, F. C., Bradford, E. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708208 · Cited by 625
Metadata
- Authors
- Crim, C., Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Willits, L. R., Yates, J. C., & Vestbo, J.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2009-05-14
- Volume
- 34
- Issue
- 3
- Pages
- 641-647
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2100738224
- Cited by
- 432
- References
- 32
- FWCI
- 20.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.